Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

310 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00110045

Conditions
Adnexal Diseases, Amyloidosis, Ataxia, +137 more
Locations
  • CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium
  • Centre Hospitalier Universitaire Henri Mondor Créteil, France
  • Hopital Edouard Herriot - Lyon Lyon, France
  • Hopital Saint-Louis Paris, France
View all 13 locations
View Trial Details
Completed

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

NCT00003805

Conditions
Blast Crisis, Blood Protein Disorders, Body Temperature Changes, +69 more
Locations
  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Algemeen Ziekenhuis Middelheim Antwerp, Belgium
  • Hopital Universitaire Erasme Brussels, Belgium
View all 28 locations
View Trial Details
Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations
  • Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
  • Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
  • Tennessee Plateau Oncology Crossville, Tennessee, United States
View Trial Details
Completed

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

NCT00003005

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations
  • Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C., District of Columbia, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
  • New England Medical Center Hospital Boston, Massachusetts, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions